Information updates

New ASCIA anaphylaxis refresher e-training for health professionals

New ASCIA anaphylaxis refresher e-training for health professionals takes around 45 minutes to complete, includes EpiPen and Anapen training, and has been developed to upskill or provide interim refresher training. The course is suitable for medical practitioners (including GPs, paediatricians and physicians), pharmacists, nurse practitioners and nurses, dietitians and other allied healthcare professionals.  To register go to

This short course includes four modules:

  • Module 1: Allergy and Anaphylaxis
  • Module 2: Adrenaline (Epinephrine) 
  • Module 3: Anaphylaxis Management, Prescribing and Referral Guidelines
  • Module 4: Final Assessment - a certificate confirms successful completion when 100% is obtained.

Learning outcomes:

1. Differentiate between a mild to moderate allergic reaction and anaphylaxis.

2. Outline acute management for mild or moderate allergic reactions and anaphylaxis.

This course should be used to upskill or as interim refresher training. It does not replace the full ASCIA anaphylaxis e-training course for health professionals, which takes around 1.5 hours to complete and includes detailed modules about epidemiology, diagnosis, acute management of anaphylaxis and allergy to stings and bites.

If health professionals have completed the full 2021 ASCIA course, but not the updated 2021-2 course which includes Anapen, as well as EpiPen training, then they can complete  ASCIA anaphylaxis refresher e-training as it includes EpiPen and Anapen training.

ASCIA gratefully acknowledges sponsors listed on the ASCIA website who provide unrestricted educational grants that have supported the development of this course.

About ASCIA anaphylaxis e-training courses

  • ASCIA has provided anaphylaxis e-training courses since 2010, and there are more than 100,000 registrations for ASCIA courses each year from Australia and New Zealand.
  • Development and updating of all ASCIA e-training courses involves an extensive review process that involves ASCIA members and other stakeholders.
  • ASCIA retains copyright and control of all ASCIA e-training courses. Content is regularly reviewed and updated when there are changes in published evidence and products. 

ASCIA anaphylaxis resources are available at

This news item was issued on 28 February 2022 by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for clinical immunology and allergy in Australia and New Zealand.  


Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia